October 2015 Issue Table Of Contents

From The Editor

• Kyle Bass – Prophet Or Fear Profiteer?

Feature Articles

• More Than The Rise In Biologics Prompts Reorg At FDA
• Strategic Options In Financing Your Biotech

Capitol Perspectives

• Recognizing Abuses, HRSA Issues Draft Guidance On 340B

Companies To Watch

• Mucosis

Deeper Dive

• Do Outcomes In Healthcare Matter When There Is Chronic Misalignment?

Outsourcing Insights

• A Look At 2015 Outsourcing Trends And What To Expect In 2016

Inside The Industry

• U.S. Biotech Meets China Capital: The Next Great Partnership?
• How Geographic Expansion Increases Risks In Biopharma
• Genentech Pushes The Clinical Trial Envelope
• The Challenge Of Moving From Transactional To Strategic Partnerships
• How You Can Boost Your Biopharma Commercial Profitability

Industry Leader

• The Challenges Surrounding Immunology
• Does Pharma Demand Forecasting Keep You Awake At Night?

Leadership Lessons

• Public Speaking: The Critical Leadership Skill

Ask The Board

• Ask The Board: What Is The Biggest Challenge For Biopharma Companies In Terms Of External Innovation?